Literature DB >> 22641763

Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management.

Nancy Scotto Rosato1, Christoph U Correll, Elizabeth Pappadopulos, Alanna Chait, Stephen Crystal, Peter S Jensen.   

Abstract

OBJECTIVE: To develop guidelines for management and treatment of maladaptive aggression in youth in the areas of psychosocial interventions, medication treatments, and side-effect management.
METHODS: Evidence was assembled and evaluated in a multistep process, including systematic reviews of published literature; an expert survey of recommended practices; a consensus conference of researchers, policymakers, clinicians, and family advocates; and review by the steering committee of successive drafts of the recommendations. The Center for Education and Research on Mental Health Therapeutics Treatment of Maladaptive Aggression in Youth guidelines reflect a synthesis of the available evidence, based on this multistep process.
RESULTS: This article describes the content, rationale, and evidence for 11 recommendations. Key treatment principles include considering psychosocial interventions, such as evidence-based parent and child skills training as the first line of treatment; targeting the underlying disorder first following evidence-based guidelines; considering individual psychosocial and medical factors, including cardiovascular risk in the selection of agents if medication treatment (ideally with the best evidence base) is initiated; avoiding the use of multiple psychotropic medications simultaneously; and careful monitoring of treatment response, by using structured rating scales, as well as close medical monitoring for side effects, including metabolic changes.
CONCLUSIONS: Treatment of children with maladaptive aggression is a "moving target" requiring ongoing assimilation of new evidence as it emerges. Based on the existing evidence, the Treatment of Maladaptive Aggression in Youth guidelines provide a framework for management of maladaptive aggression in youth, appropriate for use by primary care clinicians and mental health providers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22641763     DOI: 10.1542/peds.2010-1361

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  34 in total

1.  Pharmacological treatment of child and adolescent disruptive behaviour disorders: between the scylla and charybdis, what do the data say?

Authors:  Thomas C R Wilkes; Mary Kay Nixon
Journal:  Can J Psychiatry       Date:  2015-02       Impact factor: 4.356

2.  Assessment and Treatment of Oppositional Behaviour, Conduct Problems, and Aggression in Children and Adolescents: Creation and Dissemination of a National Curriculum.

Authors:  Tamara Pringsheim; Brendan Andrade; Asif Doja; Daniel A Gorman
Journal:  Can J Psychiatry       Date:  2017-04-07       Impact factor: 4.356

Review 3.  A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use.

Authors:  Brendan F Andrade; Darren Courtney; Stephanie Duda; Madison Aitken; Stephanie G Craig; Peter Szatmari; Joanna Henderson; Kathryn Bennett
Journal:  Clin Child Fam Psychol Rev       Date:  2019-12

4.  Trends in Atypical Antipsychotics Prescribed to Children Six Years of Age or Less on Medicaid in Kentucky.

Authors:  W David Lohr; Russell T Chowning; Michelle D Stevenson; Patricia Gail Williams
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04-21       Impact factor: 2.576

Review 5.  Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implications.

Authors:  Michael L Birnbaum; Ema Saito; Tobias Gerhard; Almut Winterstein; Mark Olfson; John M Kane; Christoph U Correll
Journal:  Curr Psychiatry Rep       Date:  2013-08       Impact factor: 5.285

Review 6.  Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerability.

Authors:  David Linton; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal:  Curr Psychiatry Rep       Date:  2013-05       Impact factor: 5.285

7.  National Patterns of Commonly Prescribed Psychotropic Medications to Young People.

Authors:  Ryan S Sultan; Christoph U Correll; Michael Schoenbaum; Marrisa King; John T Walkup; Mark Olfson
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-01-29       Impact factor: 2.576

Review 8.  Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment.

Authors:  Nitin Toteja; Juan A Gallego; Ema Saito; Tobias Gerhard; Almut Winterstein; Mark Olfson; Christoph U Correll
Journal:  Int J Neuropsychopharmacol       Date:  2013-05-14       Impact factor: 5.176

Review 9.  Disruptive mood dysregulation disorder: a new diagnostic approach to chronic irritability in youth.

Authors:  Amy Krain Roy; Vasco Lopes; Rachel G Klein
Journal:  Am J Psychiatry       Date:  2014-09       Impact factor: 18.112

Review 10.  Understanding Chronic Aggression and Its Treatment in Children and Adolescents.

Authors:  Selena R Magalotti; Mandy Neudecker; Solomon G Zaraa; Molly K McVoy
Journal:  Curr Psychiatry Rep       Date:  2019-11-18       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.